Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy

Biomedical and Environmental Sciences

Volumn 18, Issue 4, 2005, Pages 260-264

  Liu, Zhong Hua ^a,e   Wei, Ran ^b,f   Wu, Ya Ping ^b,c   Lisman, Ton ^c   Wang, Zeng Xian ^b   Han, Ji Ju ^b   Ren, Dao Ling ^b   Chen, Bin ^b   Xia, Zuo Li ^b   Chen, Biao ^d   Zhu, Zhen ^e   Zhang, Yan ^e   Cui, Xing ^f   Hu, Hai Tao ^a   De Groot, Philip G ^c   Xu, Wen Bo ^e  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f SHANDONG UNIVERSITY   (China)

Author keywords

Bio markers; Endothelial injury; SARS coronavirus; Severe acute respiratory syndrome (SARS); Soluble thrombomodulin (sTM); Tissue type plasminogen activator (t PA)

Indexed keywords

BIOLOGICAL MARKER; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHINA; FEMALE; HUMAN; MALE; PROGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MALE; PROGNOSIS; SEVERE ACUTE RESPIRATORY SYNDROME; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

SARS CORONAVIRUS;

EID: 26844566556     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To K. F., Lui, S. F., Szeto, C. C., Chung, S., and Sung J. J. (2003). A major outbreak of severe acute respiratory syndrome in Hong Kong. N. Engl. J. Med. 348, 1986-1994.
2. Wu, Y. P., Wei, R., and de, Groot. P. G. (2003). SARS in Hong Kong. N. Engl. J. Med. 349, 708-709.
3. Taylor, F. B. Jr. and Kinasewitz, G. T. (2002). The diagnosis and management of disseminated intravascular coagulation. Curr. Hematol. Rep. 1, 34-40.
4. Taylor, F. B. Jr., Toh, C. H., Hoots,W. K., Wada, H., and Levi, M. (2001). Scientific Subcommittee on Disseminated Intra. vascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring sy. stem for disseminated intravascular coagulation. Thromb. Haemost. 86, 1327-1330.
5. Wenzel, C., Kofler, J., Locker, G. J., Laczika, K., Quehenberger, P., Frass M., and Knobl P. (2002). Endothelial cell activation and blood coagulation in critically ill patients with lung injury. Wien. Klin. Wochenschr. 114, 853-858.
6. Takahashi, H., Ito, S., Hanano, M., Wada, K., Niwano, H., Seki, Y., and Shibata, A. (1992). Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am. J. Hematol. 41, 32-39.
7. Wu, K. K. and Matijevic-Aleksic, N. (2000). Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis. Ann. Med. 1(Suppl.), 73-77.
8. WHO. Severe acute respiratory syndrome (SARS). (2003). Wkly. Epidemiol. Rec. 78, 81-83.
9. Greiner, M. (1996). Two-graph receiver operating characteristic (TG-ROC): update version supports optimisation of cut-off values that minimise overall misclassification costs. Journa of Immunological Methods 191, 93-94.
10. Johnson, N. P. (2004). Advantages to transforming the receiver operating characteristic (ROC) curve into likelihood ratio co-ordinates. Stat. Med. 23, 2257-2266.
11. Henderson, A. R. (1993). Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann. Clin. Biochem. 30, 521-539.
12. Wu, E. B. and Sung, J. J. (2003). Haemorrhagic-fever-like changes and normal chest radiograph in a doctor with SARS. Lancet 361, 1520-1521.
13. Abraham E. (2000). Coagulation abnormalities in acute lung injury and sepsis. Am. J. Respir.Cell. Mol. Biol. 22, 401-404.
14. Ding ,Y. Q., Wang, H. J., Shen, H., Li, Z. G., Geng, J., Huixia, Han, H. X., Cai, J. J., Li, X., Kang, W., Weng, D. S., Lu, Y. D., Wu, D. H., Li, He., and Yao, K. T. (2003). The clinical pathology of severe acute respiratory syndrome (SARS): a report from China. J. Pathol. 200, 282-289.
15. Chen, J., Zhang, H. T., Xie, Y, Q., Wan, J. W., Lu, Z. H., Wang, D. T., Wang, Q. Z., Xue, X. H., Si ,W. X., Luo, Y. F., and Qiu, H. M. (2003). Morphological study of severe acute respiratory syndrome (SARS). Zhonghua Bing Li Xue Za Zhi. 32, 16-20.
16. Maruyama, I. and Shinmyozu K. (1994). Soluble thrombomodulin: as a marker of endothelial injury. Rinsho. Byori. 42, 563-568.
17. Morange, P. E., Simon, C, Alessi, M. C., Luc, G., Arveiler, D., Ferrieres, J., Amouyel, P., Evans, A., Ducimetiere, P., and Juhan-Vague, I. (2004). Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 109, 1343-1348.
18. Gryglewski, R. J., Chlopicki, S., Uracz, W., and Marcinkiewicz, E. (2001). Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med. Sci. Monit. 7, 1-16.
19. Ware, L. B., Fang X., and Matthay M. A. (2003). Protein C and thrombomodulin in human acute lung injury. Am. J. Physiol. Lung. Cell Mol. Physiol. 285, L514-521.
20. Califano, F., Giovanniello, T., Pantone, P., Campana, E., Parlapiano, C., Alegiani F., Vincentelli, G. M., and Turchetti, P. (2000). Clinical importance of thrombomodulin serum levels. Eur. Rev. Med. Pharmacol. Sci. 4, 59-66.
21. Nishimura, S., Ishida, T., and Imai K. (2002). Monoclonal antibody therapy for disorders of hemostasis and coagulation. Nippon. Rinsho. 60, 525-530.